Drug shown to reduce new attacks/symptom progression in some patients In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing r... Read more
Drug shown to reduce new attacks/symptom progression in some patients In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing r... Read more
Copyright 2024. Created by Innovation Toronto